In civilized countries, such as the United States, Japan, and Taiwan, the child birth of advanced women aged 35 to 39 continues to increase, and even more advanced women over forty years old also increase their possibility of child birth due to infertility treatments.
Due to the advanced age, the egg quality of the elder women becomes worse, and the rate of chromosomal abnormalities becomes higher; therefore, they are prone to have chromosome-abnormal babies and subsequent abortion.
However, in IVF, Preimplantation Genetic Testing (PGT) is designed to check embryo’s chromosomal abnormalities (including abnormal the number of chromosomes and their fragmental deletion, etc.). Proper selection of produced embryos is expected to increase the chance of IVF success.
1) advanced age, 2) habitual abortion, 3) several IVF failure. Therefore, In popular saying, IVF with PGT is called “ the 3rd generation IVF.
Preimplantation Genetic Testing (PGT) is a genetic test performed on embryos produced through IVF。
There are several old terms for genetic screening in IVF
All of these old terms, PGS, PGD, and CCS etc., are gradually replaced with PGT-A,-M,-SR.
NGS: Next-generation sequencing technology, referred to as NGS, also known as high-throughput sequencing technology, can sequence hundreds of thousands to millions of DNA molecules at a time to read and mark of long and short DNA molecules. It belongs to the second generation of gene sequencing technology, which is often used in infertility reproductive medicine and cancer medicine in medicine.
The most important feature of NGS in reproductive medicine is high-throughput sequencing, which can detect a variety of genetic changes including point mutations, gene copy number changes, and gene recombination (chromosome translocation). It is a tool for PGS and PGD.
Use NGS(next Generation Sequencing) to screen out embryos with normal chromosomes. The NGS-PGS in our institute is performed with Illumina NGS equipment and MiSeq testing platform. The provider has Illumina CSPro certified testing quality. NGS-based PGS adopts large-scale high-throughput sequencing and high-sensitivity detection, which can screen out genetic variants that cannot be read by previous technologies, and can effectively improve embryo implantation and pregnancy rates.
According to literature, the results of using NGS-based PGS are consistent with the results of using fluorescent chip (aCGH) screening. NGS-based PGS has a high detection rate of 99.98% for aneuploidies that easily cause pregnancy failure.